&nbsp;

Oct 2023

Drug

hydroxyurea

Other Name(s): Hydrea®

Quick Link(s):

Mar 2023

Drug

octreotide

Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)

Quick Link(s):

Aug 2016

Drug

oBINutuzumab

Other Name(s): Gazyva®

Quick Link(s):

May 2022

Regimen

HYDR

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

ODB - General Benefit

hydroxyurea

Drugs Used:

hydroxyurea

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

OCTR

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI),

Lung,

Neuroendocrine (Lung)

Intent: Palliative

Funding:

ODB - General Benefit

octreotide

Drugs Used:

octreotide

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

HYPERCVAD

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2022

Regimen

OXALRALT

Cancer Type:

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

New Drug Funding Program

Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Metastatic Esophageal, Gastroesophageal Junction, or Gastric Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer

Drugs Used:

raltitrexed,

oxaliplatin

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

HCKETO

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Drugs Used:

ketoconazole,

hydrocortisone

Quick Link(s):

Regimen Monograph

Jun 2017

Regimen

OPPA-COPP

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2019

Regimen

OEPA-COPDAC

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Drugs Used: